FindTrial
Sign In

Comparison of treatment planning, quality assurance and treatment implementation of Stereotactic Radiotherapy (SRT) with and without the use of Micro Multileaf Collimator (mMLC).

Dosimetric Comparison of Stereotactic Radiotherapy (SRT) Treatment plan with and without the use of Micro Multileaf Collimator (mMLC)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/037842
Enrollment
48
Registered
2021-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

RECHAL NISHA DSOUZA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CT scans of patients undergoing SRT treatment.

Exclusion criteria

Exclusion criteria: Patients unfit for Radiation therapy and being considered for hypofractionated brachytherapy procedures

Design outcomes

Primary

MeasureTime frame
â?¢ Dosimetric Comparison of Stereotactic Radiotherapy (SRT) Treatment plan with and without the use of Micro Multileaf Collimator (mMLC)Timepoint: 18 months—

Secondary

MeasureTime frame
â?¢Comparison of radiation detectors for patient-specific QA using pinpoint ionization chamber, micro-diamond detector, SRS diode detector, and 4D Octavius array detector for the plans with and without mMLC. â?¢Identifying the factors affecting performance of mMLC and non-mMLC SRT techniques. â?¢Comparison of mMLC and non mMLC techniques with regards to the practical aspects of treatment delivery. Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr KRISHNA SHARAN

MANIPAL COLLEGE OF HEALTH PROFESSIONS(MCHP),MANIPAL ACADEMY OF HIGHER EDUCATION(MAHE)

rechal.nisha@manipal.edu9964013615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026